Intellectual Property India Publishes Patent Application for Heteroaryl Compounds As Multi-Target Protein Kinase Inhibitors

MUMBAI, India, Sept. 28 -- Intellectual Property India has published a patent application (202637090218 A) filed by Fujian Haixi Pharmaceuticals Co. , Ltd. on July 24, 2026, for Heteroaryl Compounds As Multi-Target Protein Kinase Inhibitors.

Inventors include Wang, Ruyong; Zhang, Fengsen; Lian, Xin; Li, Hengdong; Gong, Xuan; Lin, Daqiang; Zheng, Zhipeng; Chen, Xin; Wu, Xueyin; Sun, Hongxue; Zhang, Yuxuan; Qiu, Lili; Li, Junqing; Chen, Guangming; and Kang, Xinshan.

The application for the patent was published on September 25, 2026, under issue no. 39/2026.

Abstract: The present disclosure provides compounds of formula (I) having receptor protein tyrosine kinase activity, and a pharmaceutically acceptable salt, stereoisomers, isotopic isom...